Byrne Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-820
Closed -$8K – 537
2023
Q2
$8K Buy
820
+120
+17% +$1.11K 0.01% 427
2023
Q1
$7K Buy
700
+60
+9% +$708 0.01% 422
2022
Q4
$7.82K Buy
640
+30
+5% +$374 0.01% 401
2022
Q3
$8K Buy
610
+60
+11% +$1.05K 0.01% 363
2022
Q2
$11K Buy
550
+40
+8% +$947 0.01% 348
2022
Q1
$13K Buy
510
+110
+28% +$2.93K 0.01% 358
2021
Q4
$11K Buy
+400
New +$12.4K 0.01% 372

Other funds holding ELAN

Byrne Asset Management's ELAN Position: Q3 2023 in Review

Byrne Asset Management sold out of Elanco Animal Health (ELAN) in Q3 2023, closing a stake of 820 shares — an estimated $8K sold.

Byrne Asset Management first reported a position in ELAN in Q4 2021 and held it in 7 quarters. The position peaked at $13K in Q1 2022. 350 funds tracked by Wall St. Rank hold ELAN as of Q3 2023.

  • Byrne Asset Management reported no remaining Elanco Animal Health position as of Q3 2023 after selling out during the quarter.
  • Byrne Asset Management sold 820 Elanco Animal Health shares in Q3 2023, an estimated $8K.
  • Byrne Asset Management first reported a position in Elanco Animal Health in Q4 2021 and held it in 7 quarters.
  • Byrne Asset Management's Elanco Animal Health position peaked at $13K in Q1 2022.
  • 350 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2023.

Based on Byrne Asset Management's 13F filing for Q3 2023, filed 31 Oct 2023.